3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
4
Phase 2
4
Phase NA
1
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
NET
1
Endocrine
1
Conditions
Neuroendocrine Tumors
1
Interventions
lutetium Lu 177 dotatate
2
Lutetium-177
2
Liquid Biopsy
2
pentetreotide
1
fluorodopa F 18
1
copper dotatate CU-64
1
Yttrium-90
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Single Photon Emission Computed Tomography Computed Tomography
1
Resveratrol
1
Respiratory Therapy
1
Referral and Consultation
1
Quality of Life
1
Poly(ADP-ribose) Polymerase Inhibitors
1
Palliative Care
1
Nutrition Assessment
1
Needles
1
Magnetic Resonance Spectroscopy
1
Endoscopic Mucosal Resection
1
Diet Therapy
1
Data Collection
1
Cryosurgery
1
Control Groups
1
Colectomy
1
Betaine
1
90Y-octreotide, DOTA-Tyr(3)-
1
3-Iodobenzylguanidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Neuroendocrine Tumors
×
177Lu-octreotide, DOTA(0)-Tyr(3)-
×
Clear all
NCT04790708
2021-03-10
FENET-2016
University Hospital of Ferrara
Phase NA
Unknown
250 enrolled